Social Capital Suvretta Holdings Corp IV Cl A (DNAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | DNAD | AZN | AMGN | GILD | BMY |
| Company | Social Capital Suvretta Holdings Corp IV Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 10.35 | 170.53 | 382.00 | 130.23 | 65.00 |
| High | 10.36 | 170.74 | 386.82 | 130.88 | 65.66 |
| Low | 10.34 | 168.44 | 379.34 | 128.76 | 63.53 |
| Last | 10.35 | 169.64 | 385.16 | 130.21 | 65.31 |
| Change | +0.01 | -1.70 | -2.48 | -1.07 | +0.45 |
| Percent Change | +0.10% | -0.99% | -0.64% | -0.82% | +0.69% |
| Volume | 144,200 | 1,670,009 | 1,953,500 | 6,529,600 | 14,579,522 |
| 20-Day Average Volume | 127,825 | 2,891,840 | 2,349,190 | 6,590,265 | 11,017,565 |
| Previous | 10.34 | 171.34 | 387.64 | 131.28 | 64.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 10.33 | 173.04 | 370.76 | 132.16 | 60.44 |
| 20-Day Raw Stochastic | 83.33% | 18.77% | 70.85% | 20.00% | 96.18% |
| 20-Day Relative Strength | 65.52 | 43.53 | 62.90 | 49.09 | 66.60 |
| Weighted Alpha | +6.50 | +4.71 | +31.56 | +10.68 | +48.35 |
| Today's Opinion | 100% Buy | 88% Sell | 100% Buy | 24% Sell | 88% Buy |
| Yesterday's Opinion | 100% Buy | 88% Sell | 100% Buy | 24% Sell | 72% Buy |
| Last Month's Opinion | 100% Buy | 24% Sell | 56% Buy | 88% Sell | Hold |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.15% since 06/23/23 | +0.22% since 07/24/26 | +2.43% since 07/24/26 | +0.70% since 07/24/26 | +5.19% since 07/24/26 |
| Low | 10.33 on 06/28/23 | 167.79 on 07/27/26 | 374.39 on 07/27/26 | 128.28 on 07/30/26 | 62.22 on 07/27/26 |
| High | 10.36 on 06/30/23 | 175.04 on 07/29/26 | 398.00 on 07/28/26 | 136.26 on 07/28/26 | 65.66 on 07/31/26 |
| 1-Month | |||||
| %Chg | +0.38% since 05/30/23 | -10.54% since 06/30/26 | +6.36% since 06/30/26 | +3.06% since 06/30/26 | +13.35% since 06/30/26 |
| Low | 10.30 on 06/01/23 | 164.06 on 07/20/26 | 353.95 on 07/15/26 | 125.13 on 07/01/26 | 56.30 on 07/01/26 |
| High | 10.36 on 06/30/23 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 65.66 on 07/31/26 |
| 3-Month | |||||
| %Chg | +1.27% since 03/30/23 | -9.46% since 04/30/26 | +11.24% since 04/30/26 | -0.48% since 04/30/26 | +7.79% since 04/30/26 |
| Low | 10.22 on 04/10/23 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 10.46 on 04/12/23 | 196.41 on 07/02/26 | 398.00 on 07/28/26 | 140.61 on 07/17/26 | 65.66 on 07/31/26 |
| 6-Month | |||||
| %Chg | +2.99% since 12/30/22 | -8.57% since 01/30/26 | +12.66% since 01/30/26 | -8.27% since 01/30/26 | +18.64% since 01/30/26 |
| Low | 10.04 on 01/04/23 | 164.06 on 07/20/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 53.44 on 06/18/26 |
| High | 10.92 on 01/12/23 | 212.71 on 02/18/26 | 398.00 on 07/28/26 | 157.29 on 02/11/26 | 65.66 on 07/31/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 330,061 | 265,732,560 | 209,212,416 | 162,993,296 | 132,448,728 |
| Shares Outstanding, K | 31,890 | 1,550,908 | 539,708 | 1,241,570 | 2,042,071 |
| Annual Sales, $M | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income, $M | 2,740,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Qtr Sales, $M | 0 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 11,489,000,000 |
| Last Qtr Income, $M | 2,460,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 2,677,000,000 |
| 60-Month Beta | 0.01 | 0.24 | 0.41 | 0.32 | 0.23 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 05/15/23 | 2.63 on 07/27/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 2.04 on 07/30/26 |
| Latest Earnings Date | 01/01/70 | 11/05/26 | 08/04/26 | 08/04/26 | 07/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | 0.630 on 07/02/26 |
| Next Ex-Dividend Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | 07/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.85 | 17.54 | 15.86 | 10.64 |